Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation

被引:16
作者
Blair, HC
Dong, SS
Julian, BA
机构
[1] Univ Alabama, Sch Med, Vet Affairs Med Ctr, Birmingham, AL 35294 USA
[2] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama, Sch Med, Dept Med, Birmingham, AL 35294 USA
[4] Univ Alabama, Sch Med, Dept Surg, Birmingham, AL 35294 USA
来源
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 1999年 / 435卷 / 01期
关键词
Kit ligand; c-Kit; steel factor; interleukin-3; bone turnover; mastocytosis; parathyroid hormone;
D O I
10.1007/s004280050394
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mast cells accumulate in hyperparathyroid bone, but the reason is not clear. We compared the distribution of mast cells and related growth factors in normal and hyperparathyroid bone. Mast cell formation was strongly affected by proximity to bone-forming surfaces of hyperparathyroid bone. Hyperparathyroidism greatly increased the production by active, bone-synthesizing osteoblasts of stem cell factor (SCF) but not of IL-3. Osteoblast SCF was distributed to the basolateral cell membranes, and its cDNA sequence (GenBank AF119835) is homologous to the murine membrane-bound SCE Quiescent osteoblasts did not produce detectable SCE Synthetic osteoblasts in normal bone were SCF positive, but comprised a much smaller population of cells, in keeping with the slow turnover of normal bone. Major SCF isoforms on immunoblot analysis of osteoblast-fraction proteins from high-turnover bone had M(r)s of about 48 and 40 kDa. Similar SCF isoforms were produced by MG63 osteoblast-derived cells and were identified by several anti-SCF antibodies. SCF is expressed in several mesenchymal cell types in a complementary fashion with cells bearing its receptor. SCF potently facilitates differentiation of mast cells, so the increase in paratrabecular mast cells in hyperparathyroid bone is probably driven by osteoblastic SCE. However, since mast cells are not normal components of bone, osteoblastic SCF probably regulates other cells, with mast cell differentiation occurring as a side effect greatly increased osteoblastic activity.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 36 条
[1]  
Alsina M, 1996, VITAM HORM, V52, P63, DOI 10.1016/S0083-6729(08)60407-0
[2]   SKELETAL MASTOCYTOSIS [J].
ANDREW, SM ;
FREEMONT, AJ .
JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (11) :1033-1035
[3]   OSTEOCLASTIC BONE-RESORPTION BY A POLARIZED VACUOLAR PROTON PUMP [J].
BLAIR, HC ;
TEITELBAUM, SL ;
GHISELLI, R ;
GLUCK, S .
SCIENCE, 1989, 245 (4920) :855-857
[4]  
BRANDT J, 1992, BLOOD, V79, P634
[5]  
DEMULDER A, 1992, J BONE MINER RES, V7, P1337
[6]   IL-3 in the clinic [J].
Eder, M ;
Geissler, G ;
Ganser, A .
STEM CELLS, 1997, 15 (05) :327-333
[7]   ILIAC BONE-MARROW MAST-CELLS IN RELATION TO RENAL OSTEODYSTROPHY OF PATIENTS TREATED BY HEMODIALYSIS [J].
ELLIS, HA ;
PEART, KM .
JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (06) :502-516
[8]   EFFECT OF RENAL-TRANSPLANTATION ON MARROW MAST-CELL HYPERPLASIA OF CHRONIC RENAL-FAILURE [J].
ELLIS, HA ;
PEART, KM ;
PIERIDES, AM .
JOURNAL OF CLINICAL PATHOLOGY, 1977, 30 (10) :960-965
[9]   Prostaglandin E(1)-induced hyperostosis: Clinicopathologic correlations and possible pathogenetic mechanisms [J].
FayePetersen, OM ;
Johnson, WH ;
Carlo, WA ;
Hedlund, GL ;
Pacifico, AD ;
Blair, HC .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1996, 16 (03) :489-507
[10]  
Gattei V, 1996, CELL GROWTH DIFFER, V7, P753